Literature DB >> 22437296

Reduction of lesion in injured rat spinal cord and partial functional recovery of motility after bone marrow derived mesenchymal stem cell transplantation.

Erdal Karaoz1, Serdar Kabatas, Gokhan Duruksu, Alparslan Okcu, Cansu Subasi, Birol Ay, Murat Musluman, Erdinc Civelek.   

Abstract

AIM: This study aimed to analyze the effect of rat bone marrow-mesenchymal stem cells (rBM-MSCs) delivery on lesion site after spinal cord injury, and to observe the functional recovery after transplantation.
MATERIAL AND METHODS: MSCs were isolated from rat femurs and tibias. The experimental rat population was divided into four groups: only laminectomy (1); laminectomy+trauma (2); laminectomy+trauma+PBS (3); laminectomy+trauma+MSCs (4). Their motility were scored regularly. After 4-weeks, rats were sacrificed, and their spinal cords were examined for GFP labeled rBM-MSCs by immunostainings.
RESULTS: In the early posttraumatic period, the ultrastructures of spinal cord tissue were preserved in Group 4. The majority of cells forming the ependymal region around the central canal were found to be MSCs. The gray-and-white-matter around the ependymal region were composed of Nestin+/GFAP+ cells, with astrocytic-like appearance. The scores showed significant motor recovery in Group 4, especially in hind limb functions. However, no obvious change was observed in other groups.
CONCLUSION: The increase Nestin+/GFAP+ cells in the gray-and-white-matter around the ependymal region could indicate the potential to self-renew and plasticity. Thus, transplantation of rBM-MSCs might be an effective strategy to improve functional recovery following spinal cord trauma. In conclusion, molecular factors in cell fate decisions could be manipulated to enhance reparative potential of cell-based therapy.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22437296     DOI: 10.5137/1019-5149.JTN.5412-11.1

Source DB:  PubMed          Journal:  Turk Neurosurg        ISSN: 1019-5149            Impact factor:   1.003


  17 in total

1.  Cross effects of resveratrol and mesenchymal stem cells on liver regeneration and homing in partially hepatectomized rats.

Authors:  Erdem Okay; Turgay Simsek; Cansu Subasi; Abdullah Gunes; Gokhan Duruksu; Yesim Gurbuz; Gulcin Gacar; Erdal Karaoz
Journal:  Stem Cell Rev Rep       Date:  2015-04       Impact factor: 5.739

Review 2.  Neurotrauma and mesenchymal stem cells treatment: From experimental studies to clinical trials.

Authors:  Ana Maria Blanco Martinez; Camila de Oliveira Goulart; Bruna Dos Santos Ramalho; Júlia Teixeira Oliveira; Fernanda Martins Almeida
Journal:  World J Stem Cells       Date:  2014-04-26       Impact factor: 5.326

3.  Bone marrow mesenchymal stem cells stimulated with low-intensity pulsed ultrasound: Better choice of transplantation treatment for spinal cord injury: Treatment for SCI by LIPUS-BMSCs transplantation.

Authors:  Guang-Zhi Ning; Wen-Ye Song; Hong Xu; Ru-Sen Zhu; Qiu-Li Wu; Yu Wu; Shi-Bo Zhu; Ji-Qing Li; Man Wang; Zhi-Gang Qu; Shi-Qing Feng
Journal:  CNS Neurosci Ther       Date:  2018-10-08       Impact factor: 5.243

4.  Effect of intravenous transplantation of bone marrow mesenchymal stem cells on neurotransmitters and synapsins in rats with spinal cord injury.

Authors:  Shaoqiang Chen; Bilian Wu; Jianhua Lin
Journal:  Neural Regen Res       Date:  2012-07-05       Impact factor: 5.135

5.  Conditioned medium from bone marrow-derived mesenchymal stem cells improves recovery after spinal cord injury in rats: an original strategy to avoid cell transplantation.

Authors:  Dorothée Cantinieaux; Renaud Quertainmont; Silvia Blacher; Loïc Rossi; Thomas Wanet; Agnès Noël; Gary Brook; Jean Schoenen; Rachelle Franzen
Journal:  PLoS One       Date:  2013-08-27       Impact factor: 3.240

6.  Stem cell therapy in spinal trauma: Does it have scientific validity?

Authors:  Harvinder Singh Chhabra; Kanchan Sarda
Journal:  Indian J Orthop       Date:  2015 Jan-Feb       Impact factor: 1.251

Review 7.  Cell therapy and delivery strategies for spinal cord injury.

Authors:  Bruna Dos S Ramalho; Fernanda M de Almeida; Ana M B Martinez
Journal:  Histol Histopathol       Date:  2021-06-10       Impact factor: 2.303

Review 8.  Cell transplantation for spinal cord injury: a systematic review.

Authors:  Jun Li; Guilherme Lepski
Journal:  Biomed Res Int       Date:  2013-01-15       Impact factor: 3.411

Review 9.  The Potential for iPS-Derived Stem Cells as a Therapeutic Strategy for Spinal Cord Injury: Opportunities and Challenges.

Authors:  Mohamad Khazaei; Ahad M Siddiqui; Michael G Fehlings
Journal:  J Clin Med       Date:  2014-12-29       Impact factor: 4.241

Review 10.  Cell Therapy Augments Functional Recovery Subsequent to Spinal Cord Injury under Experimental Conditions.

Authors:  Vikram Sabapathy; George Tharion; Sanjay Kumar
Journal:  Stem Cells Int       Date:  2015-07-09       Impact factor: 5.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.